LaGray, Inc.

LaGray, Inc. is a pioneering pharmaceutical manufacturing company committed to achieving self-sufficiency in pharmaceutical production, particularly in Africa. With the establishment of the first fully integrated pharmaceutical production facility in West Africa, LaGray adheres to international GMP standards in its design, construction, and operation. LaGray Chemical Company (Ghana) Ltd. possesses the advanced technology to manufacture both active pharmaceutical ingredients (API) and finished pharmaceutical products, ensuring the availability of life-saving medicines at affordable prices.

Located at its primary address at 6658 N. Fairfield Avenue, Chicago, Illinois 60645, US, LaGray is dedicated to providing a wide range of high-quality medicines for treating priority endemic diseases (PEDs). The company's commitment to quality extends to its outstanding service, aimed at building strong customer loyalty. With heightened awareness of counterfeit and substandard medicines in Africa, LaGray's adherence to international GMP standards makes it a highly valued and trusted provider. LaGray, Inc. also has locations in Accra-Kumasi Road P. O. Box NW 224 Nsawam, Eastern Region N/A, GH and #13, Close C, 4 Winston Churchill Street Asokoro Abuja, Federal Capital Territory, NG.

LaGray is poised for continued growth and development in the pharmaceutical sector, contributing significantly to healthcare solutions and pharmaceutical accessibility. The company's vision is to expand its impact and ensure uncompromising quality in all aspects of its operations. The information will be completed soon with the support of the company’s management. We invite the manager of LaGray to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial opportunities.